drugmakers

Ruling Against First Pharmaceutical Company in Opioid Lawsuit

[vc_row][vc_column][rev_slider_vc alias="drugmakers-sue-1"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]For the first time, a pharmaceutical company, Johnson & Johnson, has been ordered to pay a substantial sum for their role in the opioid crisis in Oklahoma. While the opioid epidemic is no doubt a nationwide crisis, Oklahoma has been particularly devastated by the highly addictive pain killer. There have reportedly been over 6,000 deaths tied to opioid abuse in Oklahoma over the last two decades. The attorney general in...

Donna White
Share
Clinical Support Systems

Clinical Support Systems and EHR

[vc_row][vc_column][rev_slider_vc alias="clinical-support-system"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]Recently Frost & Sullivan released a new report: U.S. Clinical Decision Support Systems (CDSS) Market, Forecast to 2024. Clinical Support Systems, sometimes integrated into a practice’s EHR and other times an additional tool a provider uses, is going to become critical to evaluating patients and generating a plan of care. What is a Clinical Decision Support System? These tools analyze the vast amount of patient data that is entered...

Donna White
Share
Surprise Medical Bills

Studies Show Increase in Surprise Medical Bills

[vc_row][vc_column][rev_slider_vc alias="surprise-bills199"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]Findings from 2016 data recently released by the American Medical Association show that 4 in 10 patients with private in-network insurance at hospitals faced surprise medical bills after their visit. How do surprise medical bills occur? Most often it is from visiting a hospital or ER the patient’s private insurance is in network with, however the doctors that treat them are out of network with the patient’s private insurance....

Donna White
Share
rhc

Proposed Healthcare Changes and RHC’s

[vc_row][vc_column][rev_slider_vc alias="rhcs"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]After two rounds of Democratic debates, a huge spotlight has been placed on Healthcare. While people on both sides of the aisle agree an overhaul to the system is a necessity, the agreement ends there. We have heard several proposals, and one in particular could lead to devastating consequences to America’s Rural Healthcare System. Anyone in the Revenue Cycle Industry knows that most provider’s top five payors include Medicare....

Donna White
Share
price lists

Hospitals are Posting Price Lists

[vc_row][vc_column][rev_slider_vc alias="price-lists"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]In January of this year, a rule went into effect requiring hospitals to publish their price lists, or charge masters publicly on their websites. The rule applied to all of the nearly 6,000 hospitals in the country. The idea behind the rule is to give patients the options to choose and price shop for their hospital services between their local hospitals. There are several issues standing in the way...

Donna White
Share
antibiotic

Drug Price Legislation Faces Challenges

[vc_row][vc_column][rev_slider_vc alias="drug-legistlation"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]In May we released an article about a proposed rule coming down from CMS regarding drug prices in advertising. In June we noted that drug companies were fighting this rule in court. This month we see the setbacks and challenges the Trump Administration continue to face in lowering drug prices for the everyday American. On July 8, federal courts ruled that the Department of Health and Human Services (HHS)...

Donna White
Share
executive order

Executive Order Reduces HHS Time for Transparency

[vc_row][vc_column][rev_slider_vc alias="executive-order"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]An executive order issued this week calls for the U.S. Department of Health and Human Services (HHS) to write the hospital requirements on price transparency in the next 60 days. This should mandate “standard charge information, including charges and information based on negotiated rates and for common or shoppable items.” But what are common or shoppable items? These are treatments and procedures widely available from hospitals and doctors. According...

Donna White
Share
drugmakers

Drugmakers Sue Over Drug Prices in Ads

[vc_row][vc_column][rev_slider_vc alias="drugmakers-sue"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]Pharmaceutical companies like Amgen Inc, Merk & Co, Eli Lilly and Co, as well as the Association of National Advertisers,  filed a lawsuit Friday, May 14th against the Trump Administration regarding the new CMS final rule that would go in to effect in July. This rule, we reviewed in a previous blog, states that television ads must now include drug prices, as well as the FDA rule to...

Donna White
Share
Maternity Care

Only 20% of Hospitals meet Maternity Care Performance Standards

[vc_row][vc_column][rev_slider_vc alias="maternity-care"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]Alarmingly, based on a 2017 study, the U.S. has the worst rate of maternal deaths in the developed world. Let that sink in. While mortality rates have declined throughout Europe, Australia, and Canada since 1990, the U.S.’s rate has grown exponentially. There are many reasons for this, including hospitals maternity care performance standards. Based on this 2017 study, for every 100,000 live births, there is a 26.4 maternal mortality...

Donna White
Share
Prescription Benefits

CMS Final Rule for Drug Prices in Advertising

[vc_row][vc_column][rev_slider_vc alias="cms-final-drug-rule"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]A rule proposed in October of last year has become final on May 8, 2019. This rule would mandate that pharmaceutical companies publish the prices of any medication with a list price greater than $35 during television ads. Pharmaceutical companies tried to push back on this rule stating that listing the prices would confuse patients since what they pay will be different due to insurance coverage, rebates, and discounts....

Donna White
Share